The Academy of Oncology Nurse & Patient Navigators and Gilead Sciences Partner to Launch Oncology Navigation Grant Program
The Californer/10315521

GAINESVILLE, Fla., June 1, 2025 ~ The Academy of Oncology Nurse & Patient Navigators (AONN+) has recently announced the launch of a groundbreaking grant program in collaboration with Gilead Sciences. This initiative aims to advance the field of oncology navigation and improve patient outcomes within the healthcare setting. The program will provide support for the development, enhancement, and expansion of innovative tools that optimize efficiency and elevate the critical role of oncology navigators.

After issuing a call for grant submissions in April, AONN+ received an overwhelming response from healthcare leaders across the country. The submissions included creative applications, software solution ideas, and improvements to healthcare systems. The recipients of the award, which is valued up to $500,000, will be announced in June with project work set to begin in July. AONN+ has also enlisted the help of Amplity, their association management partner and strategic collaborator, to assist with the grant application process and implementation support for awardees.

More on The Californer

• California: Update on the Golden State Plan to Counter Antisemitism
• Esteemed Barry Goldwater Scholarship Awarded to Cal Lutheran Student
• Pietryla PR & Marketing Introduces 'Jumpstart' Consulting Packages for B2B Communications Leaders
• New Book Reveals the Nine Essential Traits That Define History's Greatest Visionary Leaders
• First Entertainment Credit Union Lends Support to the Hollywood Climate Summit to Champion Green Initiatives in Entertainment

Candice Roth, MSN, RN, CENP, Executive Director of AONN+, expressed her excitement about this funding mechanism. She stated that AONN+ and Gilead are committed to addressing persistent challenges in cancer care by empowering navigators to play a crucial role in improving patient access to navigation services, removing barriers to cancer care, and supporting treatment adherence. Roth also highlighted that navigator utilization presents significant opportunities for optimizing patient outcomes and this program seeks to provide impactful solutions that directly tie proposed tools to measurable improvements in patient care.

Darren Tayama, M.D., Vice President of US Medical Affairs for Oncology at Gilead Sciences also shared his enthusiasm about this partnership. He stated that as part of Gilead's Community Cancer Collective initiative, they are proud to collaborate with AONN+ on this exciting program that supports the oncology community. Tayama believes that together with AONN+, they are advancing the future of cancer care through innovative solutions in oncology navigation.

The AONN+ and Gilead Sciences grant program is a significant step towards improving cancer care and patient outcomes. With the support of healthcare leaders and the expertise of Amplity, this initiative has the potential to make a significant impact in the field of oncology navigation.

---

Show All News | Report Violation